Researchers show that in mice, tumor-secreted cystatin-C crosses the blood–brain barrier and stimulates microglia to degrade ...

Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in diagnosis, classification, and ...

Advances in artificial intelligence and multimodal data integration are poised to revolutionise cancer diagnostics – but significant challenges remain before these technologies can be routinely ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...

As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low ...

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.

This article explores how tissue-based companion diagnostics leveraging immunohistochemistry approaches will help to select patients for targeted cancer treatments.

Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...

Valar Labs is a precision oncology company using artificial intelligence to reduce the uncertainty in cancer treatment. By analyzing standard pathology slides, Valar's AI biomarkers predict response ...

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal ...